This randomized trial compares the effect of intermediate-dose vs standard prophylactic enoxaparin on a composite outcome of acute venous thromboembolism (VTE),
Mykenzie Johnson / Unsplash
The hashtag There is no insulin (or انسولین نیست#) trended across Iran and beyond on Twitter in mid-October. Although the Iranian government said that more insulin would be available to be distributed, shortages still occurred at least through early December, and no long-term solutions have surfaced.
In 2011, an estimated 11.4% of the adult population in Iran had diagnosed diabetes, and recent articles report that Iran has more than 5 million diabetic residents, with more than 600,000 needing daily insulin injections.
While a World Health Organization (WHO) representative for Iran was not able to be reached for comment, a WHO media contact was unsure if a shortage was still occurring due to a drop in local media coverage. Iranians who still use the hashtag have crowdsourced insulin and bemoaned spot shortages, hours-long delays and bureaucratic frustrations, and rationing.